Silent Embolism during TAVR: Just Images or Potential Cognitive Deterioration?

Finding new cerebral ischemic imaging after transcatheter aortic valve replacement (TAVR) is almost the rule, especially for self-expandable valves. These images might disappear over the months but, unfortunately, they are associated to small but significative cognitive deterioration. 

Embolia silente durante el TAVI ¿solo imágenes o pueden deteriorar la cognición?

Most patients undergoing TAVR develop silent cerebral ischemic lesions (SCILs) that show in magnetic resonance imaging (MRI). The natural history of this images and their potential clinical implications were not well established in the literature. 

This study included 117 patients with baseline MRI within 7 days before TAVR and age-related white matter change score. 

After procedure, a new MRI was done to assess occurrence, localization, number and dimension of the new ischemic lesions. Patients with new lesions repeated the MRI at 3 to 5 months followup. 

In addition to MRIs, neurocognitive tests were carried out prior procedure, at discharge and at 3-month followup. 

There were new ischemic lesions in 76% of patients, distributed across all territories: a median number of 2, median diameter 4.5 mm and median total volume 140 mm³.

Independent predictors of these images were greater baseline age-related white matter deterioration and the use of self-expandable valves.  


Read also: Post TAVR Acute Coronary Syndrome: Frequency and Potential Damage.


The third MRI showed only 26.7% of patients evolved with a post procedure gliotic scar in lieu of ischemic lesions. 

After procedure, there was transient neurocognitive deterioration in all patients, but this was far more pronounced in patients with new ischemic lesions. Also, recovery was slower when there were new ischemic lesions. 

Conclusion

Silent ischemic lesions were observed in most patients undergoing TAVR. Most of these lesions can disappear over time, but they have significant cognitive impact. 

Original Title: Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement.

Reference: Marco De Carlo et al. J Am Coll Cardiol Intv 2020, article in press. https://doi.org/10.1016/j.jcin.2020.03.004.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....